Dr. Peter Arthur Burke , DO
Internal Medicine - Nephrology โข Newark, DE
4923 Ogletown Stanton Rd Ste 200
Newark, DE 19713
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Peter Burke is listed in NPPES under Internal Medicine - Nephrology.
-
NPI assigned on June 7, 2010; this date does not establish years in practice.
-
Published CMS data list 1,322 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99233 โ Subsequent hospital care with moderate levelof medical decision making: 400 service units.
- 99232 โ Subsequent hospital care with moderate levelof medical decision making: 242 service units.
- 99215 โ Established patient outpatient office visit: 196 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 13 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,436 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisone โ 177 prescription fills, including refills.
- Cinacalcet Hcl โ 102 prescription fills, including refills.
- Leflunomide โ 100 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 31 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 75% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: 3,672. Middle half: 1,322 to 3,999.
Fewer Medicare Part B services than 75% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 38 clinicians with data). Median for this group: 2,846. Middle half: 1,371 to 3,981.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,466 in 2020 to 1,322 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
4923 Ogletown Stanton Rd Ste 200
Newark, DE 19713
NPPES lists 1 additional practice-address record in Newark, DE. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 2 distinct group names: Christiana Care Health Services Inc; Nephrology Associates Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Philadelphia College Of Osteopathic Medicine
2010
What Public CMS Data Show
Internal Medicine - Nephrology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
263 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $161,338 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $127,440 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
2,835 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$528,305 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $620.02 across 27 records.
By nature of payment
- Food and Beverage: $620.02 across 27 records.
Reporting-company totals (3 largest of 13)
- Amgen Inc.: $99.40 across 5 records.
- Veloxis Pharmaceuticals, Inc.: $87.76 across 3 records.
- Merck Sharp & Dohme LLC: $85.98 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
16 years (graduated 2010)
CMS Doctors and Clinicians data list 2010 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2010
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Burke has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Burke as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Newark and Delaware
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 75% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: 3,672. Middle half: 1,322 to 3,999.
Fewer Medicare Part B services than 75% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 38 clinicians with data). Median for this group: 2,846. Middle half: 1,371 to 3,981.
Medicare-allowed amount
A lower Medicare-allowed amount than 65% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: $233,255. Middle half: $151,849 to $320,315.
A lower Medicare-allowed amount than 75% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 38 clinicians with data). Median for this group: $225,307. Middle half: $168,394 to $316,063.
Paid by Medicare
A lower Medicare payment amount than 65% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: $180,676. Middle half: $116,220 to $249,891.
A lower Medicare payment amount than 75% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 38 clinicians with data). Median for this group: $175,600. Middle half: $132,145 to $245,684.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: 819. Middle half: 428 to 1,158.
More Part D prescriptions than 80% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 40 clinicians with data). Median for this group: 836. Middle half: 471 to 1,139.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: $80,962. Middle half: $53,704 to $266,466.
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 40 clinicians with data). Median for this group: $141,395. Middle half: $43,047 to $305,235.
22 active clinicians are listed under Internal Medicine - Nephrology with a practice address in Newark, DE (52 in Delaware).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Newark
63.6% of these 22 clinicians have the CMS telehealth indicator.
77.3% of these 22 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 62% from 3,466 in 2020 to 1,322 in 2024.
- 2020: 3,466
- 2021: 4,656
- 2022: 2,007
- 2023: 1,238
- 2024: 1,322
-
Medicare-allowed amount
Medicare-allowed amount decreased 44% from $285,750 in 2020 to $161,338 in 2024.
- 2020: $285,750
- 2021: $282,160
- 2022: $203,776
- 2023: $139,488
- 2024: $161,338
-
Paid by Medicare
Paid by Medicare decreased 44% from $226,286 in 2020 to $127,440 in 2024.
- 2020: $226,286
- 2021: $220,524
- 2022: $159,564
- 2023: $110,378
- 2024: $127,440
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 10% from 1,305 in 2020 to 1,436 in 2024.
- 2020: 1,305
- 2021: 1,734
- 2022: 1,838
- 2023: 1,411
- 2024: 1,436
-
30-day fills
30-day fills increased 22% from 2,330 in 2020 to 2,835 in 2024.
- 2020: 2,330
- 2021: 3,665
- 2022: 4,077
- 2023: 3,046
- 2024: 2,835
-
Part D drug cost
Part D drug cost increased 485% from $90,363 in 2020 to $528,305 in 2024.
- 2020: $90,363
- 2021: $168,247
- 2022: $243,060
- 2023: $202,532
- 2024: $528,305
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $224.12 in 2021 to $620.02 in 2025.
- 2021: $224.12
- 2022: $392.10
- 2023: $471.11
- 2024: $465.69
- 2025: $620.02
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 27 records totaling $620.02.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $39.80 |
| Veloxis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ENVARSUS | General | $34.74 |
| Invivyd Inc |
Food and Beverage
In-kind items and services
|
PEMGARDA | General | $29.41 |
| Veloxis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ENVARSUS | General | $28.05 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
VOYXACT | General | $27.04 |
| Invivyd Inc |
Food and Beverage
In-kind items and services
|
PEMGARDA | General | $26.54 |
| Veloxis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ENVARSUS | General | $24.97 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $24.89 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
PREVYMIS | General | $24.73 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
JYNARQUE | General | $24.53 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $23.24 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
PREVYMIS | General | $22.96 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
FABRAZYME | General | $21.73 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
PREVYMIS | General | $21.43 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $21.07 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $20.79 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $20.53 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $20.19 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $20.19 |
| KYOWA KIRIN, INC. |
Food and Beverage
In-kind items and services
|
CRYSVITA | General | $19.51 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $19.33 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $19.16 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Fabhalta | General | $17.92 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $17.20 |
| Vifor Pharma, Inc. |
Food and Beverage
In-kind items and services
|
Veltassa | General | $17.06 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
400 | 94 | $130.95 | $114.03 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
242 | 86 | $98.55 | $75.98 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
196 | 80 | $467.10 | $140.08 |
|
90935
Hemodialysis procedure with physician evaluation
|
134 | 46 | $325.00 | $66.13 |
|
90960
Dialysis services, 4 or more physician visits per month (20 years or older)
|
93 | 16 | $660.00 | $343.10 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
64 | 57 | $260.00 | $163.70 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
43 | 16 | $20.00 | $14.90 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
41 | 18 | $241.26 | $151.86 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
30 | 26 | $308.65 | $94.76 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
29 | 28 | $210.00 | $126.50 |
|
99443
Telephone medical discussion with physician, 21-30 minutes
|
18 | 18 | $345.74 | $113.09 |
|
90945
Dialysis procedure including 1 evaluation
|
16 | 11 | $325.00 | $83.26 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
16 | 12 | $170.00 | $118.15 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisone | Prednisone | 177 | 7,066 | $649.85 | 44 |
| Cinacalcet Hcl | Cinacalcet Hcl | 102 | 4,846 | $66,489.19 | 23 |
| Leflunomide | Leflunomide | 100 | 4,894 | $7,251.58 | 22 |
| Amlodipine Besylate | Amlodipine Besylate | 99 | 7,282 | $785.04 | 33 |
| Methenamine Hippurate | Methenamine Hippurate | 85 | 4,233 | $6,011.22 | 17 |
| Valganciclovir Hcl | Valganciclovir Hcl | 67 | 4,809 | $23,562.20 | 27 |
| Losartan Potassium | Losartan Potassium | 66 | 5,322 | $1,080.83 | 21 |
| Tamsulosin Hcl | Tamsulosin Hcl | 65 | 5,124 | $852.93 | 26 |
| Hydralazine Hcl | Hydralazine Hcl | 64 | 4,035 | $750.51 | 21 |
| Carvedilol | Carvedilol | 63 | 4,188 | $244.57 | 26 |
| Furosemide | Furosemide | 59 | 3,300 | $190.51 | 17 |
| Nifedipine Er | Nifedipine | 50 | 3,540 | $1,679.81 | 14 |
| Entecavir | Entecavir | 45 | 2,322 | $11,351.73 | โ |
| Omeprazole | Omeprazole | 41 | 3,240 | $569.12 | 17 |
| Calcitriol | Calcitriol | 41 | 2,166 | $1,185.75 | 13 |
| Potassium Chloride | Potassium Chloride | 40 | 1,976 | $994.89 | 16 |
| Atorvastatin Calcium | Atorvastatin Calcium | 37 | 2,966 | $378.24 | 15 |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 27 | 489 | $2,384.29 | 21 |
| Clonidine Hcl | Clonidine Hcl | 25 | 1,600 | $232.27 | โ |
| Famotidine | Famotidine | 24 | 1,430 | $236.16 | โ |
| Acyclovir | Acyclovir | 22 | 1,134 | $570.05 | โ |
| Metoprolol Tartrate | Metoprolol Tartrate | 19 | 980 | $191.70 | โ |
| Allopurinol | Allopurinol | 17 | 1,284 | $68.02 | โ |
| Chlorthalidone | Chlorthalidone | 14 | 1,280 | $359.15 | โ |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | 390 | $47.94 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-06-17NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
NUCC Taxonomy Code: 208M00000X
Hospitalists are physicians whose primary professional focus is the general medical care of hospitalized patients. Their activities include patient care, teaching, research, and leadership related to Hospital Medicine. The term 'hospitalist' refers to physicians whose practice emphasizes providing care for hospitalized patients.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEPHROLOGY
I20190923002210
MD
2668612144
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Nephrology Associates Pa
137 W High St, Elkton, MD 219218614
Phone: 4106209200
Christiana Care Health Services Inc
4735 Ogletown Stanton Rd, Newark, DE 197138000
Phone: 3026233866
Nephrology Associates Pa
4923 Ogletown Stanton Rd, Newark, DE 197132081
Phone: 3022250451
Secondary Practice Locations
4755 Ogletown Stanton Rd
Newark, DE 19718
Phone: 3152694842
4755 Ogletown Stanton Rd
Newark, DE 19718
Phone: 3152694842
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Nurse Practitioner
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Osteopathic Medicine (D.O.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 4923 OGLETOWN STANTON RD STE 200, NEWARK, DE 19713 (Tel: 3022250451)
Registered at 4923 OGLETOWN STANTON RD STE 200, NEWARK, DE 197136005 (Tel: 3022250451)
Registered at 4755 OGLETOWN STANTON RD, NEWARK, DE 19718 (Tel: 3152694842)
Registered at 833 CHESTNUT ST STE 700, PHILADELPHIA, PA 191074410 (Tel: 2155033000)
NPI status registered as active in NPPES database
Registered at 4755 OGLETOWN STANTON RD, NEWARK, DE 197180001 (Tel: 3152694842)
Registered at 4755 OGLETOWN STANTON RD, NEWARK, DE 197180001 (Tel: 3152694842)
Recorded as PETER BURKE, D.O.
Internal Medicine (license number reported to NPPES: DE C2-0009881)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Nephrology Specialists in Newark
- Dr. William Dahms, DO
- Dr. Piyaporn Apivatanagul, MD
- Dr. James Torain, MD
- Dr. Carlos Machado, MD
- Dr. Feroz Abubacker Kaniyamparambil, MD
- Dr. Nealanjon Das, DO
Mailing Address
4923 Ogletown Stanton Rd Ste 200
Newark, DE 197136005
Phone: 3022250451